Skip to main content
Brioni R. Moore on Muck Rack

Brioni R. Moore

As seen in: MDPI, The Lancet, Journal of Infection
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brioni R.

Contact Brioni R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: a single arm, phase IIa trial of safety and pharmacokinetics

|
By Julie Bennett, Sam Salman, Hutt Valley, Hazel C. Dobinson, Erik Andersen, Anneka Anderson, Brioni R. Moore, Madhu Page-Sharp, Kevin T Batty, Jonathan R Carapetis, Michael Baker, Laurens Manning, Dhevindri Moodley, Joesph Kado
| Journal of Infection Verified
Keywords Rheumatic heart disease acute rheumatic fever penicillin BPG subcutaneous.injection Introduction Acute rheumatic fever (ARF) is a preventable immune-mediated inflammatory disease that occurs as a delayed sequelae to group A streptococcus (GAS; Streptococcus pyogenes) infections.1,2 ARF and its complication rheumatic heart disease (RHD) typically begin in childhood and have significant negative effects on health, often resulting in chronic illness, cardiac failure, stroke, and...
Open in Who Shared Issue with article?

The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings

|
By Tobias Strunk, Michael Petrovski, Madhu Page-Sharp, Brioni R. Moore
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Defining the combined benefit of intermittent preventive malaria treatment in pregnancy

|
By Sam Salman, Brioni R. Moore
| The Lancet Verified
WHO has included intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine as an important malaria intervention since 2012. 1 WHO WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP).
Open in Who Shared Issue with article?
See all 4 articles